Biopsy Devices Market Size, Share & Trends Analysis Report By Product Type (Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), Consumables (Forceps, Trocars, Trays, Other Consumables), By Biopsy Type, By Anatomy, By Disease Type, By Guidance Technique, By Region, And By Segment Forecasts, 2024-2031

Report Id: 2228 Pages: 180 Last Updated: 13 February 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Biopsy Devices Market-

Biopsy Devices Market By Product Type-

  • Needle Biopsy Devices
    • Guidance Systems
    • Biopsy Consoles
    • Site Markers
    • Biopsy Guns
      • Automated Systems
      • Semi-Automated Systems
    • Needles
  • Skin Biopsy Devices
    • Punch Biopsy Instruments
    • Shave Biopsy Instruments
  • Consumables
    • Forceps
    • Trocars
    • Trays
    • Other Consumables

Biopsy devices

Biopsy Devices Market By Biopsy Type

  • Tissue Biopsy
    • Needle Biopsy
    • Surgical Biopsy
    • Skin Biopsy
  • Liquid Biopsy

Biopsy Devices Market By Anatomy-

  • Breast
  • Lung
  • Bone
  • Liver
  • Uterus/Cervix/Ovary
  • Abdomen
  • Prostate
  • Cardiac
  • Skin
  • Others

Biopsy Devices Market By Disease Type-

  • Cancer
  • Infections
  • Autoimmune Disorders
  • Non-Cancerous Indications
  • Others

Biopsy Devices Market By Guidance Technique -

  • Ultrasound-Guided Biopsy
  • X-Ray-Guided Biopsy
  • MRI-Guided Biopsy
  • CT-Guided Biopsy

Biopsy Devices Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Biopsy Devices Market Snapshot

Chapter 4. Global Biopsy Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis

5.1. By Product, & Market Share, 2019 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019  to 2031 for the following By Product:

5.2.1. Needle Biopsy Devices

5.2.1.1. Guidance Systems

5.2.1.2. Biopsy Consoles

5.2.1.3. Site Markers

5.2.1.4. Biopsy Guns

5.2.1.4.1. Automated Systems

5.2.1.4.2. Semi-Automated Systems

5.2.1.5. Needles

5.2.2. Skin Biopsy Devices

5.2.2.1. Punch Biopsy Instruments

5.2.2.2. Shave Biopsy Instruments

5.2.3. Consumables

5.2.3.1. Forceps

5.2.3.2. Trocars

5.2.3.3. Trays

5.2.3.4. Other Consumables

Chapter 6. Market Segmentation 2: By Biopsy Type Estimates & Trend Analysis

6.1. By Biopsy Type & Market Share, 2019 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Biopsy Type:

6.2.1. Tissue Biopsy

6.2.1.1. Needle Biopsy

6.2.1.2. Skin Biopsy

6.2.1.3. Surgical Biopsy

6.2.2. Liquid Biopsy

Chapter 7. Market Segmentation 3: By Disease Type Estimates & Trend Analysis

7.1. By Disease Type & Market Share, 2019 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Disease Type:

7.2.1. Cancer

7.2.2. Infections

7.2.3. Autoimmune Disorders

7.2.4. Non-Cancerous Indications

7.2.5. Others

Chapter 8. Market Segmentation 4: By Anatomy Estimates & Trend Analysis

8.1. By Anatomy & Market Share, 2019 & 2031

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Anatomy:

8.2.1. Breast

8.2.2. Lung

8.2.3. Bone

8.2.4. Liver

8.2.5. Uterus/Cervix/Ovary

8.2.6. Abdomen

8.2.7. Prostate

8.2.8. Cardiac

8.2.9. Skin

8.2.10. Others

Chapter 9. Market Segmentation 5: By Guidance Technique Estimates & Trend Analysis

9.1. By Guidance Technique & Market Share2019 2020 & 2031

9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Guidance Technique:

9.2.1. X-Ray-Guided Biopsy

9.2.2. Ultrasound-Guided Biopsy

9.2.3. MRI-Guided Biopsy

9.2.4. CT-Guided Biopsy

Chapter 10. Biopsy Devices Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031

10.1.2. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Biopsy Type, 2024-2031

10.1.3. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Disease Type, 2024-2031

10.1.4. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Anatomy, 2024-2031

10.1.5. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Guidance Technique, 2024-2031

10.1.6. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

10.2. Europe

10.2.1. Europe Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031

10.2.2. Europe Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031

10.2.3. Europe Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031

10.2.4. Europe Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031

10.2.5. Europe Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031

10.2.6. Europe Biopsy Devices Market revenue (US$ Million) by country, 2024-2031

10.3. Asia Pacific

10.3.1. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031

10.3.2. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031

10.3.3. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031

10.3.4. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031

10.3.5. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031

10.3.6. Asia Pacific Biopsy Devices Market revenue (US$ Million) by country, 2024-2031

10.4. Latin America

10.4.1. Latin America Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031

10.4.2. Latin America Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031

10.4.3. Latin America Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031

10.4.4. Latin America Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031

10.4.5. Latin America Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031

10.4.6. Latin America Biopsy Devices Market revenue (US$ Million) by country, 2024-2031

10.5. Middle East & Africa

10.5.1. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031

10.5.2. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031

10.5.3. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031

10.5.4. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031

10.5.5. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031

10.5.6. Middle East & Africa Biopsy Devices Market revenue (US$ Million) by country, 2024-2031

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Argon Medical Devices, Inc.

11.2.2. B. Braun SE

11.2.3. Becton, Dickinson and Company

11.2.4. Boston Scientific Corporation

11.2.5. Cardinal Health, Inc.

11.2.6. Cook Group Incorporated

11.2.7. Conmed Corporation

11.2.8. FUJIFILM Holdings Corporation

11.2.9. GE Healthcare

11.2.10. Inrad, Inc.

11.2.11. Medtronic plc

11.2.12. Olympus Corporation

11.2.13. Siemens Healthineers AG

11.2.14. Stryker Corporation

11.2.15. Zamar Care

11.2.16. Changzhou Jiuhong Medical Instrument Co., Ltd.

11.2.17. Kindly (KDL) Meditech

11.2.18. Ningbo Xinwell Medical Technology Co., LTD.

11.2.19. Shenzhen Manners Technology Co., Ltd.

11.2.20. Zhejiang Soudon Medical Technology Co., Ltd

11.2.21. Agilent Technologies, Inc.

11.2.22. BGI Group

11.2.23. Biocept, Inc.

11.2.24. Bio-Rad Laboratories, Inc.

11.2.25. Dxcover Limited

11.2.26. Elypta Limited

11.2.27. F. Hoffmann-La Roche Ltd

11.2.28. Illumina, Inc.

11.2.29. Micronoma

11.2.30. QIAGEN

11.2.31. Revvity, Inc.

11.2.32. Sysmex Corporation

11.2.33. Thermo Fisher Scientific Inc.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1998
Security Code field cannot be blank!

Frequently Asked Questions

Biopsy Devices Market Size is valued at USD 6.84 Bn in 2023 and is predicted to reach USD 20.04 Bn by the year 2031

Biopsy Devices Market expected to grow at a 14.51% CAGR during the forecast period for 2024-2031.

F. Hoffmann-La Roche Ltd, Illumina, Inc., Micronoma, QIAGEN, Revvity, Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying